Cargando…
The cannabinoid dehydroxylcannabidiol suppresses neuropathic pain by upregulating a spinal glycine receptor-mediated compensation mechanism
Neuropathic pain (NP) is well-known to be complicated and challenging to manage. Organisms have been shown to initiate various intrinsic compensatory strategies to alleviate NP, which could be utilized to aid the development of therapeutic treatments. However, these mechanisms that alleviate NP have...
Autores principales: | Xia, Jing, Xiao, Dan, Luo, Heyi, Jin, Jin, Ge, Siyuan, Wang, Xianglian, Zou, Guichang, Xiong, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248534/ http://dx.doi.org/10.1016/j.jbc.2023.104769 |
Ejemplares similares
-
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
por: Xiong, Wei, et al.
Publicado: (2012) -
Human Hyperekplexic Mutations in Glycine Receptors Disinhibit the Brainstem by Hijacking GABA(A) Receptors
por: Zou, Guichang, et al.
Publicado: (2019) -
Cannabinoid CB2 receptors are upregulated via bivalent histone modifications and control primary afferent input to the spinal cord in neuropathic pain
por: Ghosh, Krishna, et al.
Publicado: (2022) -
Spinal cannabinoid receptor 2 activation alleviates neuropathic pain by regulating microglia and suppressing P2X7 receptor
por: Zhou, Yifan, et al.
Publicado: (2023) -
Targeting the endogenous cannabinoid system to treat neuropathic pain
por: Lau, Benjamin K., et al.
Publicado: (2014)